Inflammatory Biomarkers to Detect Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Lung Cancer Patients Ready for Prime Time?

被引:2
作者
Aras, Mandar A. [1 ]
Power, John R. [2 ,3 ]
Moslehi, Javid J. [2 ,3 ]
机构
[1] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA
[2] Vanderbilt Univ, Med Ctr, Cardiooncol Program, Div Cardiovasc Med,Dept Med, Nashville, TN USA
[3] Vanderbilt Univ, Med Ctr, Cardiooncol Program, Div Oncol,Dept Med, Nashville, TN USA
来源
JACC: CARDIOONCOLOGY | 2020年 / 2卷 / 03期
关键词
immune checkpoint inhibitors; inflammatory markers; myocarditis; neutrophil-to-lymphocyte ratio; DEFINITIONS; MYOCARDITIS;
D O I
10.1016/j.jaccao.2020.08.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:503 / 505
页数:3
相关论文
共 15 条
  • [1] Myocarditis in the Setting of Cancer Therapeutics Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology
    Bonaca, Marc P.
    Olenchock, Benjamin A.
    Salem, Joe-Elie
    Wiviott, Stephen D.
    Ederhy, Stephane
    Cohen, Ariel
    Stewart, Garrick C.
    Choueiri, Toni K.
    Di Carli, Marcelo
    Allenbach, Yves
    Kumbhani, Dharam J.
    Heinzerling, Lucie
    Amiri-Kordestani, Laleh
    Lyon, Alexander R.
    Thavendiranathan, Paaladinesh
    Padera, Robert
    Lichtman, Andrew
    Liu, Peter P.
    Johnson, Douglas B.
    Moslehi, Javid
    [J]. CIRCULATION, 2019, 140 (01) : 80 - 91
  • [2] Molecular analysis of the RET and NTRK1 gene rearrangements in papillary thyroid carcinoma in the Polish population
    Brzezianska, Ewa
    Karbownik, Malgorzata
    Migdalska-Sek, Monika
    Pastuszak-Lewandoska, Dorota
    Wloch, Jan
    Lewinski, Andrzej
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2006, 599 (1-2) : 26 - 35
  • [3] Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
    Curigliano, G.
    Lenihan, D.
    Fradley, M.
    Ganatra, S.
    Barac, A.
    Blaes, A.
    Herrmann, J.
    Porter, C.
    Lyon, A. R.
    Lancellotti, P.
    Patel, A.
    DeCara, J.
    Mitchell, J.
    Harrison, E.
    Moslehi, J.
    Witteles, R.
    Calabro, M. G.
    Orecchia, R.
    de Azambuja, E.
    Zamorano, J. L.
    Krone, R.
    Iakobishvili, Z.
    Carver, J.
    Armenian, S.
    Ky, B.
    Cardinale, D.
    Cipolla, C. M.
    Dent, S.
    Jordan, K.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 (02) : 171 - 190
  • [4] PD-1 Modulates Radiation-Induced Cardiac Toxicity through Cytotoxic T Lymphocytes
    Du, Shisuo
    Zhou, Lin
    Alexander, Gregory S.
    Park, Kyewon
    Yang, Lifeng
    Wang, Nadan
    Zaorsky, Nicholas G.
    Ma, Xinliang
    Wang, Yajing
    Dicker, Adam P.
    Lu, Bo
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : 510 - 520
  • [5] Hicks KA, 2015, J AM COLL CARDIOL, V66, P403, DOI [10.1016/j.jacc.2014.12.018, 10.1007/s12350-015-0209-1]
  • [6] Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
    Hodi, F. Stephen
    O'Day, Steven J.
    McDermott, David F.
    Weber, Robert W.
    Sosman, Jeffrey A.
    Haanen, John B.
    Gonzalez, Rene
    Robert, Caroline
    Schadendorf, Dirk
    Hassel, Jessica C.
    Akerley, Wallace
    van den Eertwegh, Alfons J. M.
    Lutzky, Jose
    Lorigan, Paul
    Vaubel, Julia M.
    Linette, Gerald P.
    Hogg, David
    Ottensmeier, Christian H.
    Lebbe, Celeste
    Peschel, Christian
    Quirt, Ian
    Clark, Joseph I.
    Wolchok, Jedd D.
    Weber, Jeffrey S.
    Tian, Jason
    Yellin, Michael J.
    Nichol, Geoffrey M.
    Hoos, Axel
    Urba, Walter J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (08) : 711 - 723
  • [7] Cardiovascular toxicities associated with immune checkpoint inhibitors
    Hu, Jiun-Ruey
    Florido, Roberta
    Lipson, Evan J.
    Naidoo, Jarushka
    Ardehali, Reza
    Tocchetti, Carlo G.
    Lyon, Alexander R.
    Padera, Robert F.
    Johnson, Douglas B.
    Moslehi, Javid
    [J]. CARDIOVASCULAR RESEARCH, 2019, 115 (05) : 854 - 868
  • [8] Fulminant Myocarditis with Combination Immune Checkpoint Blockade
    Johnson, Douglas B. dbj
    Balko, Justin M. jmb
    Compton, Margaret L. mlc
    Chalkias, Spyridon sc
    Gorham, Joshua jc
    Xu, Yaomin yx
    Hicks, Mellissa mh
    Puzanov, Igor ip
    Alexander, Matthew R. mra
    Bloomer, Tyler L. tlb
    Becker, Jason R. jrb
    Slosky, David A. das
    Phillips, Elizabeth J. ejp
    Pilkinton, Mark A. map
    Craig-Owens, Laura lco
    Kola, Nina nk
    Plautz, Gregory gp
    Reshef, Daniel S. dsr
    Deutsch, Jonathan S. jsd
    Deering, Raquel P. rpd
    Olenchock, Benjamin A. bao
    Lichtman, Andrew H. ahl
    Roden, Dan M. dmr
    Seidman, Christine E. ces
    Koralnik, Igor J. ijk
    Seidman, Jonathan G. jgs
    Hoffman, Robert D. rdh
    Taube, Janis M. jmt
    Diaz, Luis A. Jr lad
    Anders, Robert A. raa
    Sosman, Jeffrey A. jas
    Moslehi, Javid J. jjm
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (18) : 1749 - 1755
  • [9] Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting
    Moey, Melissa Y. Y.
    Tomdio, Anna N.
    McCallen, Justin D.
    Vaughan, Lauren M.
    O'Brien, Kevin
    Naqash, Abdul R.
    Cherry, Cynthia
    Walker, Paul R.
    Carabello, Blase A.
    [J]. JACC: CARDIOONCOLOGY, 2020, 2 (03): : 491 - 502
  • [10] Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer A National Cancer Database Survey
    Morgensztern, Daniel
    Ng, Shean Huey
    Gao, Feng
    Govindan, Ramaswamy
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (01) : 29 - 33